Bivalirudin contraindications: Difference between revisions

Revision as of 18:53, 21 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Bivalirudin#Contraindications]]
-{{Bivalirudin}}
-{{CMG}} {{AE}}{{JH}}
-==Contraidications==
+[[Category: Cardiovascular Drugs]]
+[[Category: Drug]]
-Angiomax is contraindicated in patients with:
+[[Category: Anticoagulants]]
-Active major bleeding;
-Hypersensitivity (e.g., anaphylaxis) to Angiomax or its components [see Adverse Reactions (6.3)].<ref>{{Cite web  | last =  | first =  | title = ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=911cd48f-01ea-4dec-b30c-95e7e0ea9d2a | publisher =  | date =  | accessdate = 10 March 2014 }}</ref>
-==References==
-{{Reflist}}
-{{FDA}}
-[[Category:Cardiovascular Drugs]]
-[[Category:Drugs]]